FRM
BSX icon

Fox Run Management’s Boston Scientific BSX Stock Holding History

Fox Run Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
16,055
+632
+4% +$50.6K 0.18% 172
2025
Q4 		$1.47M Sell
15,423
-7,183
-32% -$704K 0.23% 85
2025
Q3 		$2.21M Buy
+22,606
New +$2.34M 0.34% 16
2025
Q2 		– Sell
-2,369
Closed -$239K – 886
2025
Q1 		$239K Sell
2,369
-6,020
-72% -$606K 0.04% 745
2024
Q4 		$749K Sell
8,389
-3,373
-29% -$297K 0.14% 282
2024
Q3 		$986K Buy
+11,762
New +$927K 0.22% 130
2023
Q2 		– Sell
-4,455
Closed -$223K – 707
2023
Q1 		$223K Buy
+4,455
New +$210K 0.07% 496
2022
Q3 		– Sell
-20,558
Closed -$766K – 618
2022
Q2 		$766K Buy
20,558
+15,538
+310% +$632K 0.38% 34
2022
Q1 		$222K Buy
+5,020
New +$218K 0.12% 380
2021
Q4 		– Sell
-11,573
Closed -$502K – 485
2021
Q3 		$502K Sell
11,573
-2,048
-15% -$90.6K 0.32% 78
2021
Q2 		$582K Buy
+13,621
New +$573K 0.53% 22
2020
Q4 		– Sell
-6,353
Closed -$243K – 200
2020
Q3 		$243K Buy
6,353
+430
+7% +$16.6K 0.61% 80
2020
Q2 		$208K Buy
+5,923
New +$213K 0.28% 202
2018
Q2 		– Sell
-28,077
Closed -$767K – 685
2018
Q1 		$767K Sell
28,077
-7,123
-20% -$194K 0.19% 166
2017
Q4 		$873K Buy
+35,200
New +$971K 0.26% 92
2017
Q3 		– Sell
-20,200
Closed -$560K – 676
2017
Q2 		$560K Buy
+20,200
New +$536K 0.19% 186
2017
Q1 		– Sell
-40,200
Closed -$870K – 576
2016
Q4 		$870K Buy
+40,200
New +$877K 0.46% 14

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fox Run Management's BSX Position: Q1 2026 in Review

Fox Run Management increased its Boston Scientific (BSX) stake by 4.1% in Q1 2026, buying an estimated $50.6K and bringing the position to 16,055 shares worth $1.01M. The position accounts for 0.18% of the portfolio, ranked #172.

Fox Run Management first reported a position in BSX in Q4 2016 and has held it in 17 quarters since. The position peaked at $2.21M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Fox Run Management held 16,055 shares of Boston Scientific worth $1.01M as of Q1 2026.
  • Fox Run Management bought 632 Boston Scientific shares in Q1 2026, an estimated $50.6K.
  • Boston Scientific made up 0.18% of Fox Run Management's portfolio in Q1 2026, its #172 holding.
  • Fox Run Management first reported a position in Boston Scientific in Q4 2016 and has held it in 17 quarters since.
  • Fox Run Management's Boston Scientific position peaked at $2.21M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.